Insights and inspirations

For years, Hormone Replacement Therapy (HRT), also known as Menopausal Hormone Therapy (MHT), was viewed with caution following the 2002 Women's Health Initiative (WHI) study. Today, however, new research and updated clinical guidelines paint a more balanced picture. For many women experiencing perimenopause, menopause, or early postmenopause, HRT can be a safe and highly effective treatment when prescribed appropriately. The Benefits of HRT Current research consistently shows that HRT remains the gold standard for treating moderate to severe menopausal symptoms. Relief from Menopause Symptoms Hormone therapy is the most effective treatment for: Hot flashes and night sweats Sleep disturbances Mood changes and irritability Vaginal dryness and painful intercourse Urinary symptoms Joint aches and muscle discomfort Many women report significant improvements in quality of life within weeks of beginning treatment. Supports Bone Health Declining estrogen accelerates bone loss, increasing the risk of osteoporosis and fractures. Studies continue to show that HRT helps preserve bone density and significantly reduces fracture risk, particularly when started near menopause. May Improve Heart Health—When Started at the Right Time Research supports the "timing hypothesis," suggesting women who begin HRT before age 60 or within 10 years of menopause may experience cardiovascular benefits compared with women who initiate therapy much later. Timing, formulation, and individual health history all matter. Better Brain Function and Quality of Life While HRT is not recommended to prevent dementia, many women experience improvements in: Brain fog Sleep quality Mood Energy Overall quality of life These improvements often result from better symptom control rather than direct effects on cognitive aging. Understanding the Risks HRT is not appropriate for everyone. Potential risks include: Increased risk of blood clots, particularly with some oral estrogen formulations Small increase in breast cancer risk with long-term combined estrogen-progestogen therapy Stroke risk may increase with advancing age or when therapy begins well after menopause Women with a history of estrogen-sensitive cancers, unexplained vaginal bleeding, active liver disease, or previous blood clots may not be candidates for systemic HRT. Importantly, research now shows that the type of hormone, route of administration (oral vs. transdermal), dosage, and timing of treatment significantly influence risk. Personalized Medicine Is the Future No two women experience menopause the same way. Hormone needs vary based on genetics, metabolism, age, medical history, and symptom severity. At Fact DNA, we believe personalized hormone care begins with data. Comprehensive hormone testing and genetic insights can help healthcare providers better understand how your body processes hormones and support more individualized treatment decisions. While laboratory results are only one part of the clinical picture, they can provide valuable information when combined with symptoms and a thorough medical evaluation. The Bottom Line The conversation around HRT has changed dramatically. Modern evidence shows that, for many healthy women in perimenopause and early postmenopause, the benefits of hormone therapy often outweigh the risks when treatment is individualized and monitored by an experienced healthcare provider. Knowledge empowers better decisions. Understanding your hormones—and how your body responds to them—can help you navigate menopause with greater confidence and improved quality of life. References Mukherjee A, Davis SR. Update on Menopause Hormone Therapy: Current Indications and Unanswered Questions. Clinical Endocrinology. 2025. Bofill Rodriguez M, et al. Long-term Hormone Therapy for Perimenopausal and Postmenopausal Women. Cochrane Database of Systematic Reviews. 2025. Menopausal Hormone Therapy—Risks, Benefits and Emerging Options: A Narrative Review. International Journal of Molecular Sciences. 2025. The Effects of Menopausal Hormone Therapy on Cardiovascular Disease, Cancer, Cognition and Depression in Younger Women: A Systematic Review. 2026.

Many women wonder whether a simple blood test can tell them if they need hormone replacement therapy (HRT). The answer is more nuanced. While hormone testing can provide valuable information, healthcare providers typically diagnose perimenopause and menopause based on symptoms, age, menstrual history, and overall health—not hormone levels alone.

While the average age of menopause is approximately 51, some women experience menopause much earlier. Early menopause occurs between ages 40 and 45, while premature menopause (or premature ovarian insufficiency) occurs before age 40.

Not every woman chooses hormone therapy, and many combine lifestyle changes with medical treatment.

Nutrition plays an important role in overall wellness. Amino acids are naturally occurring compounds that serve as building blocks for proteins and participate in numerous normal processes throughout the body.